2022 ECWM共识声明:华氏巨球蛋白血症的诊断

2022-11-26 欧洲华氏巨球蛋白血症联盟 Leukemia 发表于上海

本文提出了WM诊断的共识建议和实验室要求,并提供了多参数流式细胞术、荧光原位杂交和分子检测的程序指导。

中文标题:

2022 ECWM共识声明:华氏巨球蛋白血症的诊断

英文标题:

Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia

发布日期:

2022-11-26

简要介绍:

华氏巨球蛋白血症(WM)是一种 IgM相关的淋巴浆细胞性淋巴瘤,由于疾病表现形式不同,诊断可能具有挑战性。本文提出了WM诊断的共识建议和实验室要求,并提供了多参数流式细胞术、荧光原位杂交和分子检测的程序指导。此外,近年来,WM在诊断方面取得了显著进展,对疾病生物学的理解也更加深入,这对临床实践产生了影响。再加上现有的工具和技术种类越来越多,因此有必要为临床医生对WM患者进行初步评估提供实际指导。在本文中,我们介绍了欧洲瓦尔登斯特伦巨球蛋白血症联盟(ECWM)针对临床实践和研究/学术环境制定的诊断WM的共识建议和实验室要求。我们提供了多参数流式细胞仪、荧光原位杂交和分子测试的程序,并以此为指导,对意义不明确的IgM单克隆遗传病、无症状和有症状的WM患者进行标准化的诊断工作和方法学工作流程。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 ECWM共识声明:华氏巨球蛋白血症的诊断.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3fab91c002832528, title=2022 ECWM共识声明:华氏巨球蛋白血症的诊断, enTitle=Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia, guiderFrom=Leukemia, authorId=0, author=, summary=本文提出了WM诊断的共识建议和实验室要求,并提供了多参数流式细胞术、荧光原位杂交和分子检测的程序指导。, cover=https://img.medsci.cn/20221128/1669606433407_1608702.jpg, journalId=0, articlesId=null, associationId=3667, associationName=欧洲华氏巨球蛋白血症联盟, associationIntro=欧洲华氏巨球蛋白血症联盟(ECWM,European Consortium for Waldenström´s Macroglobulinemia), copyright=0, guiderPublishedTime=Sat Nov 26 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>华氏巨球蛋白血症(WM)是一种 IgM相关的淋巴浆细胞性淋巴瘤,由于疾病表现形式不同,诊断可能具有挑战性。本文提出了WM诊断的共识建议和实验室要求,并提供了多参数流式细胞术、荧光原位杂交和分子检测的程序指导。此外,近年来,WM在诊断方面取得了显著进展,对疾病生物学的理解也更加深入,这对临床实践产生了影响。再加上现有的工具和技术种类越来越多,因此有必要为临床医生对WM患者进行初步评估提供实际指导。在本文中,我们介绍了欧洲瓦尔登斯特伦巨球蛋白血症联盟(ECWM)针对临床实践和研究/学术环境制定的诊断WM的共识建议和实验室要求。我们提供了多参数流式细胞仪、荧光原位杂交和分子测试的程序,并以此为指导,对意义不明确的IgM单克隆遗传病、无症状和有症状的WM患者进行标准化的诊断工作和方法学工作流程。</p> </div> </div> </div>, tagList=[TagDto(tagId=39132, tagName=华氏巨球蛋白血症)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=69, categoryName=检验病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3504, appHits=23, showAppHits=0, pcHits=429, showPcHits=3481, likes=0, shares=2, comments=2, approvalStatus=1, publishedTime=Thu Dec 01 21:00:00 CST 2022, publishedTimeString=2022-11-26, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Mon Nov 28 11:28:36 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Sat Jan 06 20:33:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ECWM共识声明:华氏巨球蛋白血症的诊断.pdf)])
2022 ECWM共识声明:华氏巨球蛋白血症的诊断.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2124590, encodeId=8ff221245908f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60e51531845, createdName=kjdoctor, createdTime=Sun Apr 09 14:34:50 CST 2023, time=2023-04-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103815, encodeId=dd65210381539, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73c15161109, createdName=146b8551m87暂无昵称, createdTime=Thu Dec 01 23:12:31 CST 2022, time=2022-12-01, status=1, ipAttribution=江苏省)]
    2023-04-09 kjdoctor 来自河南省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2124590, encodeId=8ff221245908f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60e51531845, createdName=kjdoctor, createdTime=Sun Apr 09 14:34:50 CST 2023, time=2023-04-09, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103815, encodeId=dd65210381539, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73c15161109, createdName=146b8551m87暂无昵称, createdTime=Thu Dec 01 23:12:31 CST 2022, time=2022-12-01, status=1, ipAttribution=江苏省)]
    2022-12-01 146b8551m87暂无昵称 来自江苏省

    感谢

    0